Liquid biopsy analysis is a promising field with numerous emerging applications. The liquid biopsy is currently being utilized as a first line test in non-small cell lung cancer, especially when tissue biopsy is not an option or when there is insufficient material on tissue biopsy for standard of care molecular testing. In this webinar, we will review basic concepts of liquid biopsy testing, overview common technologies utilized by laboratories across the country, and discuss current and potential future applications.
- Review the background and basics of liquid biopsy testing
- Describe the most common methodologies employed in liquid biopsy analysis
- Overview emerging clinical applications and the testing landscape
Abhijit A. Patel, MD, PhD
Pranil Chandra, DO, FCAP